Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-22

Clinical Trial Update: SSAT067 PK of Atazanavir/Cobicistat and Darunavir/Cobicistat [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic update for fixed-dose combinations atazanavir/cobicistat (Evotaz) and darunavir/cobicistat (Prezcobix) is provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EVOTAZ (atazanavir and cobicistat)
  • PREZCOBIX (darunavir ethanolate and cobicistat)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 1 | Status: COMPLETED